Format

Send to

Choose Destination
Immunotherapy. 2015;7(6):591-4. doi: 10.2217/imt.15.33. Epub 2015 Jun 22.

Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapy.

Author information

1
Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.

KEYWORDS:

IGHV1–69; MERS-CoV; animal model; biodefense; emerging pathogen; human monoclonal antibodies; humoral immunity; passive immunotherapy; spike protein; zoonosis

PMID:
26098703
PMCID:
PMC5068219
DOI:
10.2217/imt.15.33
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center